Ally Bridge MedAlpha US Fund L.P. — Form D/A

Ally Bridge MedAlpha US Fund L.P. of NEW YORK, NY, a pooled investment fund, filed a Form D amendment with the SEC on 2024-11-15. $12.8M was reported sold. Industry: Pooled Investment Fund.

Offering

Filed: 2024-11-15
Form: D/A
Accession: 0000919574-24-006816
Industry: Pooled Investment Fund
Exemptions: 06b, 3C, 3C.7
Amount sold: $12.8M
Minimum investment: $100K
Investors: 8
Date of first sale: 2018-03-01
Security types: fund interests
SEC file number: 021-299107

Issuer

Name: Ally Bridge MedAlpha US Fund L.P.
CIK: 0001722672
Entity type: Limited Partnership
Jurisdiction: DELAWARE
Incorporated: 2017
Address: 430 PARK AVENUE, 12TH FLOOR, NEW YORK, NY, 10022
Phone: (646) 809-3771

Officers, directors & promoters (14)

Name	Role	Location
-- Ally Bridge Group (HK) Limited	Executive Officer	Central, Hong Kong, K3
- Ally Bridge MedAlpha Management L.P.	Executive Officer	Grand Cayman, E9
- Ally Bridge MedAlpha Management L.P.	Promoter	Grand Cayman, E9
- Ally Bridge MedAlpha General Partner L.P.	Executive Officer	Grand Cayman, E9
- Ally Bridge MedAlpha General Partner L.P.	Promoter	Grand Cayman, E9
- Ally Bridge Group (NY) LLC	Executive Officer	New York, NY
- Ally Bridge Group (NY) LLC	Promoter	New York, NY
- Ally Bridge Group (HK) Limited	Executive Officer	Central, Hong Kong, K3
- Ally Bridge Group (HK) Limited	Promoter	Central, Hong Kong, K3
N/A Ally Bridge Group (HK) Limited	Executive Officer	Hong Kong, K3
N/A Ally Bridge Group (NY) LLC	Executive Officer	New York, NY
N/A Ally Bridge MedAlpha Management L.P.	Executive Officer	Grand Cayman, E9
N/A Ally Bridge MedAlpha Management L.P.	Promoter	Grand Cayman, E9
N/A Ally Bridge MedAlpha General Partner L.P.	Executive Officer	Grand Cayman, E9

Other filings by this issuer (8)

Filed	Form	Offering	Sold
2025-11-14	D/A	—	$14.0M
2023-11-17	D/A	—	$12.8M
2022-11-17	D/A	—	$12.8M
2021-11-19	D/A	—	$12.4M
2020-11-20	D/A	—	$5.2M
2019-11-20	D/A	—	$3.4M
2018-11-20	D/A	—	$3.1M
2017-11-20	D	—	—

More